C
쓰리빌리언
394800KOSDAQ48.5 / 100
Reference Date: 2026-10-23
Financial Score18.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 25.2% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
3billion is a company leading the diagnosis and development of treatments for rare diseases using AI-based genome interpretation technology, offering genetic testing services such as whole genome and whole exome sequencing. As of 2025, it generates revenue in 75 countries, with 67.4% of sales coming from overseas, and has launched its own genetic variant interpretation software 'GEBRA' as a SaaS product.
Number of Employees
196people
Average Salary
67.2M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
6.93Industry Average 1.200.0Point
5.8x industry avg (risky)
ROE
-20.87Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
11.50Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲102.8% (1-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲20.6% (1-year basis)
ROE Trend
0.0 / 4
Avg ROE -26.8% (improving, 2yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (7%, downtrend)
Current 5,140Won52-week high 18,80052-week low 4,105
1-month return6.0Point
1m +25.21% (strong rise)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
3 totalPositive 0Neutral 3Negative 0
- Neutral기업설명회(IR)개최2026-10-13
- Neutral주식등의대량보유상황보고서(약식)2026-10-02
- Neutral기업설명회(IR)개최2026-10-01